Invivyd, Inc.
NASDAQ: IVVD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William E. Duke Jr.
- Employees
- 99
- Headquarters
- Waltham, United States
- IPO year
- 2021
- Market cap
- $275.1M
- Website
- https://adagiotx.com
Loading IVVD…
Loading profile data…Frequently asked questions about IVVD
What does Invivyd, Inc. (IVVD) do?
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phas...
Where does IVVD trade?
Invivyd, Inc. (IVVD) trades on the NASDAQ Global Market.
What sector is IVVD in?
Invivyd, Inc. (IVVD) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Invivyd, Inc.?
William E. Duke Jr. is the chief executive officer of Invivyd, Inc. (IVVD).
Where is Invivyd, Inc. headquartered?
Invivyd, Inc. is headquartered in United States.
Does IVVD pay a dividend?
Invivyd, Inc. (IVVD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IVVD go public?
Invivyd, Inc. (IVVD) completed its initial public offering in 2021.